Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kaiser

Showing results (781-790 of 942) with videos related to

Pageof 95
Sort By:
Chemical Biology & Drug Design|January 29, 2013
7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compoundsElaine S Coimbra, Luciana M R Antinarelli, Adilson D da Silva, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Magnetic Resonance in Chemistry : MRC|March 11, 2008
Anisotropic and hydrogen bonding effects in phenylglyoxamides and mandelamides: theoretical and NMR conformational evaluationBiank T Gonçalves, Pierre M Esteves, Angelo C Pinto, et al.
European Journal of Clinical Investigation|July 3, 1998
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot studyM P Look, J K Rockstroh, G S Rao, et al.
European Journal of Medical Research|May 19, 2007
Fatal pneumonia associated with human metapneumovirus (HMPV) in a patient with myeloid leukemia and adenocarcinoma in the lungA Müller, B Kupfer, J Vehreschild, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 2007
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]M Oette, R Kaiser, M Däumer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replicationJ P Kleim, R Bender, R Kirsch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2022
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO StudyC Grohé, W Blau, W Gleiber, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Human Gene Therapy|January 20, 1996
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase geneA A Elshami, J C Kucharczuk, H B Zhang, et al.
Pageof 95

Showing results (781-790 of 942) with videos related to

Sort By:
Pageof 95
Chemical Biology & Drug Design|January 29, 2013
7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compoundsElaine S Coimbra, Luciana M R Antinarelli, Adilson D da Silva, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Magnetic Resonance in Chemistry : MRC|March 11, 2008
Anisotropic and hydrogen bonding effects in phenylglyoxamides and mandelamides: theoretical and NMR conformational evaluationBiank T Gonçalves, Pierre M Esteves, Angelo C Pinto, et al.
European Journal of Clinical Investigation|July 3, 1998
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot studyM P Look, J K Rockstroh, G S Rao, et al.
European Journal of Medical Research|May 19, 2007
Fatal pneumonia associated with human metapneumovirus (HMPV) in a patient with myeloid leukemia and adenocarcinoma in the lungA Müller, B Kupfer, J Vehreschild, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 2007
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]M Oette, R Kaiser, M Däumer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replicationJ P Kleim, R Bender, R Kirsch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2022
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO StudyC Grohé, W Blau, W Gleiber, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Human Gene Therapy|January 20, 1996
Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase geneA A Elshami, J C Kucharczuk, H B Zhang, et al.
Pageof 95